Seasonal in Medical Technology

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... clinical study in the elderly population with our seasonal Flu vaccine." "The accomplishments ... is currently in Phase II trials with a VLP based seasonal flu vaccine candidate. The Company plans to initiate a Phase II study with its seasonal Flu vaccine candidate in the elderly population ...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

... of intravenous (i.v.) peramivir in patients with seasonal influenza. The studies were sponsored by ... Korea. In patients with uncomplicated seasonal influenza, Shionogi conducted a three-armed, ... peramivir in Japan for the treatment of seasonal and potentially life-threatening influenza. In ...

Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis

... ease IC symptoms, especially when patients have seasonal allergies. And during allergy seasons, doctors ... each other. Hubbard was sending IC patients with seasonal allergies to Smith, and Smith had allergy ... Foods Fingered Although IC patients' seasonal allergy miseries are what gave the clue to the ...

Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial

... trial of its trivalent virus-like particle (VLP) seasonal influenza vaccine. This Phase IIa randomized, ... another step in the development of Novavax's VLP seasonal influenza vaccine, allowing further evaluation of ... evaluated a trivalent VLP vaccine against the seasonal influenza strains that circulated in the ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... Intramuscular Peramivir Phase 2 Study Results for seasonal Influenza BioCryst also announced ... (i.m.) peramivir for the treatment of seasonal influenza. While the study demonstrated a ... and 600 mg. i.v. peramivir for the treatment of seasonal influenza in the outpatient setting. The Phase 2 ...

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

... Attenuated Influenza Vaccine (LAIV) for annual seasonal use. The candidate vaccine is composed of ... by the World Health Organization (WHO) for seasonal vaccine, in an intranasal device. The LAIV ... an important tool in the prevention against seasonal Influenza illness." The initiation of the ...

Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference

... vaccine production. Support for VLP seasonal Influenza Vaccine Candidate Novavax has a seasonal influenza VLP vaccine candidate in Phase II ... of influenza each year (H3N2, H1N1, and B). seasonal influenza causes over 500,000 deaths worldwide ...

Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate

... Favorable immunogenicity results for seasonal vaccine program follows positive results from its ... in July 2008; plans to initiate a study of the seasonal vaccine in the elderly in 2009 ... from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate. The ...

NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting

... vaccine solution for avian and seasonal flu ROCKVILLE, Md., Sept. 29 ... an H5N1 avian influenza vaccine and a seasonal influenza vaccine using the company's proprietary ... manufacturing solutions for producing avian and seasonal influenza vaccines with portable equipment that ...

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

... prevent pandemic influenza." Support for VLP seasonal Influenza Vaccine Candidate These data are also ... of another Novavax vaccine candidate: against seasonal influenza. Seasonal influenza causes over 500,000 ... seasonal (human) influenza strains. While current seasonal vaccines consist almost entirely of HA, the ...

BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting

... efficacy for i.v. peramivir in the treatment of seasonal influenza," commented Rich Whitley, ... peramivir in Japan for the treatment of seasonal and potentially life-threatening human influenza. ... 600 mg dose to placebo in the treatment of seasonal influenza. The dose was selected based upon an ...

BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza

... of i.m. peramivir to placebo in the treatment of seasonal influenza. The dose was selected based upon an ... BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is ... to advance development of peramivir to treat seasonal and life-threatening influenza. In February ...

Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile

... development program and in an ambitious seasonal and pandemic influenza vaccine production plan. ... also on track to build a facility to manufacture seasonal influenza vaccine in China for the local market. ... With the production of 180-million doses of seasonal influenza vaccine last year, sanofi pasteur ...

Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)

... with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung ... of how to treat patients with asthma and seasonal allergies, two diseases that often are seen in ... age 15 and up who had both persistent asthma and seasonal allergies. Patients received one of four ...

Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate

... planned IND Filing for Novavax's seasonal Influenza Vaccine Candidate ROCKVILLE, Md., ... late stage development for both the pandemic and seasonal flu vaccine programs by the second half of ... this year." The company is also preparing its seasonal VLP vaccine candidate for head-to-head human ...

Novavax Reports Fourth Quarter and 2007 Year-End Financial Results

... in the third quarter of 2008. -- Advanced its seasonal influenza program into pre-clinical studies with ... pandemic influenza study bode well for our seasonal program, because immunogenicity of the avian H5N1 antigens is not as robust as seasonal flu due to the fact that the H5N1 is not a ...

Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program

... preclinical studies of its recombinant trivalent seasonal influenza virus-like particle (VLP) vaccine. The trivalent seasonal influenza vaccine is the second of two influenza ... and B. The study showed that when all three seasonal influenza VLPs were given as a single trivalent ...

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter

... the development of Baxter's cell-cultured seasonal and pandemic influenza candidate vaccines. CSC ... 4, 2006. The contract funds development of the seasonal influenza vaccine through U.S. Food and Drug ... of a Phase 3 trial in healthy adults using the seasonal vaccine candidate in the U.S. on Nov. 26, and ...

Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs

... this study in July. -- Advanced our trivalent seasonal flu vaccine program into preclinical studies. ... -- Pre-clinical results for our trivalent seasonal flu VLP vaccine candidate. -- Completion of ... to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. ...

GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.

... is the same phenomenon that allows new strains of seasonal flu virus to circulate and cause disease year ... (IDB). GSK's FluLaval(R) and Fluviral(R) seasonal influenza vaccines for use in North America and ... PA, to develop and manufacture cell-culture based seasonal and pandemic influenza vaccines. These ...

American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission

... if illness occurs. H1N1 Flu (Swine Flu) presents symptoms similar to seasonal flu such as fever, lethargy, lack of appetite, coughing, body aches and ... is still important that people receive their annual influenza vaccination. seasonal influenza and its complications are responsible for an average of 226,000 ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... vaccine coverage in the event of a bird-flu epidemic; and prevention of seasonal influenza among school-age children by holding in-school immunization days ... College of Medicine will report progress against a more common threat - seasonal influenza. In the Temple-Belton area of central Texas, medical ...

Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!'

... committed to supporting public health efforts to reduce the incidence of seasonal influenza and to protecting more people against this potentially deadly ... 20 percent of school age children recommended to be vaccinated against seasonal influenza actually received the vaccine.(9) We hope that offering these ...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

... adjuvant to be used as a dose-sparing agent with protein-based commercial seasonal influenza vaccine and with protein-based H5N1 pandemic influenza vaccine ... for the first time today demonstrated that Vaxfectin(R)-formulated seasonal influenza vaccine generated broader, more balanced antibody responses than ...

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine

... Company, to further develop Vero cell culture-based candidate pandemic and seasonal influenza vaccines. Baxter is working with the U.S. Department of Health and Human Services, in partnership with DVC LLC, on a seasonal Phase III clinical trial that is currently underway in the United States ...

FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

... allergies affect as many as 40 million people in the United States. seasonal allergic rhinitis (SAR), commonly referred to as "hay fever" or "outdoor ... common form of allergic rhinitis. By definition, SAR includes allergies to seasonal pollens like grass, trees, and weeds, as well as mold. Perennial Allergic ...

BioCryst Updates Peramivir Clinical Development Plan

... A future pandemic remains a serious threat to global health. Additionally, seasonal influenza and related complications result in an estimated 40,000 deaths ... BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with ...

Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program

... these initial results from our pandemic trial bode well for our trivalent seasonal influenza vaccine, which is expected to enter human clinical trials during ... Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match ...

Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

... BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with ... contract to BioCryst for advanced development of peramivir to treat seasonal and life-threatening influenza. In February 2007 BioCryst established a ...

BioCryst Provides Forodesine HCl Update

... BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with ... contract to BioCryst for advanced development of peramivir to treat seasonal and life-threatening influenza. In February 2007 BioCryst established a ...

Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine

... offers Sanofi Pasteur a promising and reliable production method for seasonal and pandemic influenza vaccines in addition to traditional, proven ... the U.S. and Europe with the goal of developing new influenza vaccines. seasonal Influenza Overview Influenza is a highly infectious virus that spreads ...

BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)

... BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with ... contract to BioCryst for advanced development of peramivir to treat seasonal and life-threatening influenza. In February 2007 BioCryst established a ...

Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant

... adjuvant significantly boosted the immune response to a protein-based seasonal influenza vaccine. Mice were vaccinated with trivalent inactivated ... used as a dose-sparing agent with conventional influenza vaccines against seasonal or pandemic influenza strains; whether Vical or others will continue ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... the influenza A(H1N1) 2009 monovalent vaccines using the same regulatory process by which it approves new viral strains contained in the annual seasonal influenza vaccines. Sanofi Pasteur's influenza A(H1N1) 2009 monovalent vaccine supplemental application specifies the evaluation of a non-adjuvanted ...

Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus

... by a commercial laboratory to aid in the identification of patients infected with the novel H1N1 virus and differentiate patients infected with other seasonal Influenza A strains. Focus Diagnostics has a track record of being first to market with new laboratory testing services for emerging infectious ...

Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture

... through food, these results - positive or negative - will not have any effect on the food chain. This virus spreads the same way that the seasonal flu does every year - through the coughs, sneezes, and germs of people that are infected. Pork and pork products, whether they come from Smithfield ...

Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer

... is now an internationally recognized biotechnology company developing several vaccines and therapeutic proteins. Green Cross will become the only seasonal influenza vaccine manufacturer in South Korea and also is developing avian influenza vaccine. In its vaccine business, Green Cross has successfully ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... with a variety of DNA vaccines in multiple animal models as well as dose-sparing and immune-enhancing ability in animals with a conventional seasonal influenza vaccine. RapidResponse(TM) DNA Vaccine Manufacturing Update New data presented at the current conference indicates that a ...

Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate

... the early stage of Novavax's product candidates under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may ...

Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated

... zip code, site visitors can receive a list of immunization clinics in their area. Site visitors may also schedule reminders and sign up to receive seasonal influenza news. The Flu Clinic Locator will remain active as long as public influenza immunization clinics are offered. The Flu Clinic Locator can be ...